Forget SCHD: This Monthly Dividend Grower Out-Returned It by 38% Over the Last Decade
View original at finance.yahoo.comForget SCHD: This Monthly Dividend Grower Out-Returned It by 38% Over the Last Decade Quick Read DGRW outpaced SCHD 75% to 51% over five years and pays monthly dividends versus SCHD's quarterly schedule, making it more practical for retirees…
O que extraímos desta fonte
The claims Via News extracted from this document. We point to the source; we don't replace it.
DGRW's 0.28% expense ratio is 4.5 times higher than SCHD's 0.06%
60% confidenceSCHD tracks the Dow Jones U.S. Dividend 100 Index, a rules-based screen emphasizing sustainable yield, cash flow to debt, return on equity, and consistent dividend growth
60% confidenceSCHD pays a higher headline yield than the broad market but earns that yield by underweighting sectors that have led U.S. equity returns for most of the last decade
60% confidenceDGRW pays monthly dividends versus SCHD's quarterly schedule, making it more practical for retirees
60% confidenceThe analyst who called NVIDIA in 2010 has named his top 10 AI stocks and DGRW did not make the cut
60% confidenceSCHD charges a 0.06% expense ratio and holds roughly $95.1 billion in net assets
60% confidenceSCHD's value tilt drove a 25.78% trailing-year return compared to DGRW's 17.86%
60% confidenceDGRW outpaced SCHD 75% to 51% over the trailing five years on a price-adjusted total return basis
60% confidenceOver ten years SCHD returned 232% versus DGRW's 270%, an outperformance of 38 percentage points
60% confidenceSCHD's top ten positions include Texas Instruments at 5.59%, UnitedHealth Group at 5.55%, Qualcomm at 5.53%, Coca-Cola at 4.08%, Chevron at 3.94%, and Merck at 3.90%
60% confidenceOver the trailing five years SCHD returned 51% and DGRW returned 74.9% on a price-adjusted basis
60% confidenceIn calendar year 2025, DGRW returned 12.51% while SCHD returned 4.56%
60% confidence
Data points we hold from this source
| Merck & Co., Inc. · market share | 3.90 percent |
